Predictive Potential of C<sub>max</sub> Bioequivalence in Pilot Bioavailability/Bioequivalence Studies, through the Alternative ƒ<sub>2</sub> Similarity Factor Method
Pilot bioavailability/bioequivalence (BA/BE) studies are downsized trials that can be conducted prior to the definitive pivotal trial. In these trials, 12 to 18 subjects are usually enrolled, although, in principle, a sample size is not formally calculated. In a previous work, authors recommended th...
Main Authors: | Sara Carolina Henriques, Paulo Paixão, Luis Almeida, Nuno Elvas Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/10/2498 |
Similar Items
-
Alternative Analysis Approaches for the Assessment of Pilot Bioavailability/Bioequivalence Studies
by: Sara Carolina Henriques, et al.
Published: (2023-05-01) -
PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS
by: N. E. Uvarova, et al.
Published: (2018-12-01) -
Comparative assessment of saliva and plasma for drug bioavailability and bioequivalence studies in humans
by: Nasir M. Idkaidek
Published: (2017-07-01) -
Open questions on bioequivalence: the case of cholecalciferol
by: Antonio Marzo, et al.
Published: (2013-09-01) -
Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic
by: D. P. Romodanovsky, et al.
Published: (2021-03-01)